LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.
LevitasBio has raised $11.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
LevitasBio's investors include Pavilion Capital, Decheng Capital, Novalis LifeSciences.
LevitasBio is headquartered in San Francisco, United States.
LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.
LevitasBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LevitasBio — Funding & Investors." VCBacked, March 28, 2024, https://www.vcbacked.co/company/levitasbio. Accessed November 13, 2026.
VCBacked. (2024). LevitasBio — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/levitasbio
{{cite web |title=LevitasBio — Funding & Investors |url=https://www.vcbacked.co/company/levitasbio |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at LevitasBio? Request a listing update